1 Hershey Drive
Smiths Falls, ON K7A 0A8
Branche: Drug Manufacturers—Specialty & Generic
|Mr. David Eric Klein||CEO & Director||2,79M||N/A||1964|
|Mr. Rade Nikola Kovacevic||Advisor||971,26k||1,49M||1986|
|Mr. Michael Alan Lee||Advisor||984,36k||N/A||1973|
|Mr. Julious C. Grant Jr.||Chief Commercial Officer||686,07k||N/A||1968|
|Ms. Judy Eunjoo Hong||VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and Interim CFO||N/A||N/A||1972|
|Mr. Andrew MacCorquodale||COO & VP of Operations Transformation||N/A||N/A||N/A|
|Mr. Thomas Carlton Stewart||VP & Chief Accounting Officer||N/A||N/A||1982|
|Mr. Thomas Shipley IV||Sr. VP of Quality Assurance & Chief Science Officer||N/A||N/A||1989|
|Ms. Holly Lukavsky||Chief HR Officer||N/A||N/A||N/A|
|Mr. Timothy Rob Saunders F.C.A., FCPA||Strategic Advisor||N/A||N/A||1961|
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Canopy Growth Corporations ISS Governance QualityScore, Stand 26. September 2021, lautet 4. Die grundlegenden Scores sind Audit: 8, Vorstand: 2, Shareholderrechte: 4, Kompensation: 6.